Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 15-Jun-23 4:22 PM View:  | Mirum Pharmaceuticals, Inc. (MIRM) | 13-Jun-23 | Disposition (other) | 2,000,000 | -- | -- | (48%) 4.19M to 2.19M | |
| 02-Dec-22 5:01 PM View: | Akouos, Inc. (AKUS) | 30-Nov-22 | Disposition (change in control) | 4,294,210 | -- | -- | (100%) 4.29M to 0 | |
| 26-May-22 6:26 PM View: | Genocea Biosciences, Inc. (GNCA) | 25-May-22 | Sale | 4,445,090 | $0.08 | $362,720.00 | (100%) 4.45M to 0 | |
| 26-May-22 6:26 PM View: | Genocea Biosciences, Inc. (GNCA) | 24-May-22 | Sale | 5,931,840 | $0.07 | $387,942.00 | (57%) 10.38M to 4.45M | |
| 13-Apr-22 5:00 PM View: | Trevi Therapeutics, Inc. (TRVI) | 11-Apr-22 | Purchase | 2,631,580 | $1.90 | $5,000,000.00 | 34% 7.79M to 10.42M | |
| 27-Dec-21 4:40 PM View: | Metacrine, Inc. (MTCR) | 22-Dec-21 | Market Sale | 459,700 | $0.97 | $444,853.00 | (15%) 3.02M to 2.56M | 14% |
| 27-Dec-21 4:40 PM View: | Metacrine, Inc. (MTCR) | 10-Dec-21 | Market Sale | 37,570 | $1.32 | $49,630.00 | (1%) 3.06M to 3.02M | 37% |
| 19-Oct-21 9:09 PM View: | Trevi Therapeutics, Inc. (TRVI) | 18-Oct-21 | Purchase | 1,851,850 | -- | -- | 31% 5.94M to 7.79M | |
| 18-Mar-21 5:08 PM View: | Marker Therapeutics, Inc. (MRKR) | 16-Mar-21 | Market Purchase | 5,714,280 | $1.75 | $10,000,000.00 | 114% 5.0M to 10.71M | (100%) |
| 22-Sep-20 5:40 PM View: | Metacrine, Inc. (MTCR) | 18-Sep-20 | Conversion | 2,291,300 | -- | -- | 100% 0 to 2.29M | |
| 22-Sep-20 5:40 PM View: | Metacrine, Inc. (MTCR) | 18-Sep-20 | Purchase | 769,230 | $13.00 | $9,999,990.00 | 34% 2.29M to 3.06M | |
| 28-Jul-20 5:19 PM View: | Genocea Biosciences, Inc. (GNCA) | 24-Jul-20 | Private Purchase | 3,151,260 | $2.25 | $7,090,340.00 | 44% 7.23M to 10.38M | |
| 01-Jul-20 5:45 PM View: | Akouos, Inc. (AKUS) | 30-Jun-20 | Conversion | 3,705,970 | -- | -- | 100% 0 to 3.71M | |
| 01-Jul-20 5:45 PM View: | Akouos, Inc. (AKUS) | 30-Jun-20 | Purchase | 588,235 | $17.00 | $10,000,000.00 | 16% 3.71M to 4.29M | |
| 13-Apr-20 9:26 PM View: | Trevi Therapeutics, Inc. (TRVI) | 03-Apr-20 | Market Sale | 564 | $2.66 | $1,500.24 | (< 1%) 5.94M to 5.94M | 54% |
| 13-Apr-20 9:26 PM View: | Trevi Therapeutics, Inc. (TRVI) | 03-Apr-20 | Exercise (in-the money or at-the-money) | 1,500,000 | $0.00 | $1,500.00 | 34% 4.44M to 5.94M | |
| 24-Jul-19 4:51 PM View: | Mirum Pharmaceuticals, Inc. (MIRM) | 22-Jul-19 | Conversion | 3,736,240 | -- | -- | 100% 0 to 3.74M | |
| 24-Jul-19 4:51 PM View: | Mirum Pharmaceuticals, Inc. (MIRM) | 22-Jul-19 | Purchase | 450,000 | $15.00 | $6,750,000.00 | 12% 3.74M to 4.19M | |
| 25-Jun-19 4:48 PM View: | Genocea Biosciences, Inc. (GNCA) | 24-Jun-19 | Market Purchase | 2,857,140 | $3.50 | $10,000,000.00 | 65% 4.37M to 7.23M | (24%) |
| 13-May-19 5:10 PM View: | Trevi Therapeutics, Inc. (TRVI) | 09-May-19 | Conversion | 1,938,560 | -- | -- | 100% 0 to 1.94M | |
| 13-May-19 5:10 PM View: | Trevi Therapeutics, Inc. (TRVI) | 09-May-19 | Purchase | 2,500,000 | $10.00 | $25,000,000.00 | 129% 1.94M to 4.44M | |
| 19-Feb-19 5:00 PM View: | Genocea Biosciences, Inc. (GNCA) | 14-Feb-19 | Private Purchase | 9,948,270 | $0.47 | $4,688,620.00 | 40% 25.0M to 34.95M |